19.07.2022 • NewsPfizerBioNTechCOVID-19

EMA Reviewing Pfizer/BioNTech Covid Shot for Youngest

Pfizer and BioNTech have filed an application with the European Medicines Agency (EMA) for approval of the Comirnaty Covid-19 vaccine in children aged six months to five years.

The application requests authorization of a 3-µg dose vaccine administered as a three-dose series, the same terms greenlighted by the US Food and Drug Administration in mid-June.

Prior to that, the FDA’s advisory committee unanimously supported the authorization of the Pfizer/BioNTech and Moderna vaccines for the youngest children. Even more than their European counterparts, US parents had been clamoring for the vaccine to be made available to this age group.

For the European authorization, the Comirnaty manufacturers submitted data from a Phase 2/3 randomized, controlled study with 4,526 children aged six months to five years. The study showed that three doses of the vaccine offered a robust immune response with a safety profile similar to a placebo.

According to the companies, adverse events were less common in the youngest age group compared to children between the ages of five and 12.

Author: Dede Williams, Freelance Journalist

© Shutterstock
© Shutterstock

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.